Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Disease”

9,438 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 9,438 results

Testing effectiveness (Phase 2)Looking for participantsNCT06807606
What this trial is testing

Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation

Who this might be right for
Hematologic Malignancies
M.D. Anderson Cancer Center 35
Not applicableWithdrawnNCT07195617
What this trial is testing

Clinical Study on Evaluating the Safety and Effectiveness of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Third-line or Above Treatment

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Guangzhou Bio-gene Technology Co., Ltd
Testing effectiveness (Phase 2)Study completedNCT00002652
What this trial is testing

Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
University of Arkansas
Not applicableUnknownNCT06516458
What this trial is testing

Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis Relapse+1 more
Shirley Ryan AbilityLab 40
Testing effectiveness (Phase 2)Looking for participantsNCT06716658
What this trial is testing

JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas

Who this might be right for
Lymphoma, T-CellNK-LGL LeukemiaT-LGL Leukemia+7 more
Institute of Hematology & Blood Diseases Hospital, China 48
Early research (Phase 1)Study completedNCT01149915
What this trial is testing

Study of Hypoxia-Activated Prodrug TH-302 to Treat Advanced Leukemias

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+3 more
Threshold Pharmaceuticals 40
Not applicableActive Not RecruitingNCT07393204
What this trial is testing

Italian Real-World Study of Epcoritamab in Relapsed or Refractory DLBCL

Who this might be right for
Relapsed Diffuse Large B-cell Lymphoma (DLBCL)Refractory Diffuse Large B-Cell Lymphoma
Andrés José Maria Ferreri 150
Not applicableEnded earlyNCT00253552
What this trial is testing

G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
OHSU Knight Cancer Institute 4
Early research (Phase 1)Looking for participantsNCT04234048
What this trial is testing

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

Who this might be right for
T-cell LymphomaCutaneous/Peripheral T-Cell LymphomaPeripheral T-cell Lymphoma+8 more
SciTech Development, Inc. 46
Testing effectiveness (Phase 2)Study completedNCT00244985
What this trial is testing

Rituximab and Liposomal Doxorubicin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Roswell Park Cancer Institute 42
Early research (Phase 1)Not Yet RecruitingNCT07720843
What this trial is testing

TAlquetamab and BeLantamab Mafodotin in Relapsed/Refractory Multiple Myeloma (TaBleMM)

Who this might be right for
Relapse Multiple MyelomaRefractory Multiple Myeloma
Montefiore Medical Center 50
Post-approval studies (Phase 4)Study completedNCT00230217
What this trial is testing

Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy

Who this might be right for
TumorsHyperuricemiaTumor Lysis Syndrome
Sanofi 94
Early research (Phase 1)Study completedNCT03730363
What this trial is testing

Pentamidine + Salvage Chemo for Relapsed/Refractory Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin LymphomaRefractory Hodgkin Lymphoma
Reinhold Munker 1
Not applicableStudy completedNCT04872621
What this trial is testing

Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient Investigation

Who this might be right for
Relapsed or Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Lymphoma)
AstraZeneca 104
Testing effectiveness (Phase 2)Active Not RecruitingNCT02143414
What this trial is testing

Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaB Acute Lymphoblastic LeukemiaB Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1+2 more
National Cancer Institute (NCI) 53
Testing effectiveness (Phase 2)Looking for participantsNCT03011814
What this trial is testing

Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma

Who this might be right for
Folliculotropic Mycosis FungoidesRecurrent Cutaneous T-Cell Non-Hodgkin LymphomaRecurrent Mycosis Fungoides+5 more
City of Hope Medical Center 78
Testing effectiveness (Phase 2)Looking for participantsNCT06812858
What this trial is testing

PD-1 Inhibitors Maintenance for cHL Post-autoHCT

Who this might be right for
Hodgkin Lymphoma
St. Petersburg State Pavlov Medical University 83
Early research (Phase 1)UnknownNCT05135858
What this trial is testing

Dose Dense Re-challenge of High Dose Methotrexate With Glucarpidase for Relapsed Primary Central Nervous System Lymphoma

Who this might be right for
Primary Central Nervous System Lymphoma
Assistance Publique - Hôpitaux de Paris 18
Not applicableStudy completedNCT04616755
What this trial is testing

Stability of Maxillary Anterior Teeth After Two Years of Retention in Adolescents Comparing Two Bonded and a Vacuum-formed Retainer

Who this might be right for
Orthodontic Appliance Complication
Kronoberg County Council 90
Testing effectiveness (Phase 2)Ended earlyNCT00664378
What this trial is testing

Efficacy Study of CYT997 in Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma
Gilead Sciences 5
Next Page